Physician profile
Michael Vranian
NPI 1083939607
$2,254.13
in general payments reported to CMS, 2019-2025
12 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $202 · 2021: $232 · 2022: $333 · 2023: $577 · 2024: $194 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,466.42 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Heartmate Touch |
| Medtronic Vascular, INC. | $396.70 | 2019-2020 | |
| Becton, Dickinson and Company | $126.28 | 2024 | Hemosphere |
| Alnylam Pharmaceuticals INC. | $76.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $46.90 | 2022-2023 | Camzyos |
| Abiomed | $39.50 | 2025 | |
| Atricure, INC. | $23.05 | 2024 | |
| Merck Sharp & Dohme LLC | $19.35 | 2022 | |
| Scpharmaceuticals INC. | $16.93 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.73 | 2021 | |
| Pfizer INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vranian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.